Universities are not just teaching and researching. We are critical economic infrastructure.” – Professor Gillian Murray, ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Martin Gleave discussing how to optimize tissue biopsy ...
At ECR 2026, UII reaffirmed its AI development principles, which are anchored in clinical validation, regulatory rigor, and ...
16hon MSN
I had to man up and get a mammogram
Breast cancer isn't just a 'pink' disease; for men with a family history or genetic predisposition, a mammogram can be a ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI ...
Tuberculosis can silently affect male fertility by damaging reproductive organs, leading to reduced sperm health and ...
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results